Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pilot study examining associations between DYRK1A and α-synuclein dementias.

Neuro-degenerative diseases - 1 Jan 2012

Jones Emma L, Aarsland Dag, Londos Elisabet, Ballard Clive

Abstract excerpt

BACKGROUND: DYRK1A is a kinase targeting several proteins associated with the pathology of dementias, including α-synuclein and amyloid precursor protein. It is not clear if DYRK1A genetics are associated with neurodegenerative conditions. OBJECTIVE: To determine if DYRK1A also has a genetic association with α-synuclein dementias such as dementia with Lewy bodies and Parkinson's disease dementia. METHODS: DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Dyrk Kinases
Share to Intermediate Filament Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lewy Body Disease

Share to Pilot Projects

Share to Protein Serine-Threonine Kinases

Share to Protein-Tyrosine Kinases

Share to Psychiatric Status Rating Scales

Source

Identifiers

PMID: 22269890
DOI: 10.1159/000334759

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

A pilot study examining associations between DYRK1A and α-synuclein dementias.PMID 22269890Read ↗

Association of DYRK1A polymorphisms with sporadic Parkinson's disease in Chinese Han population.Semantic proximity Read ↗

Parkinsonism, Lrrk2 G2019S, and tau neuropathology.Semantic proximity Read ↗

Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.Semantic proximity Read ↗

DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort.Semantic proximity Read ↗

Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications.Semantic proximity Read ↗

Kinases as Targets for Parkinson's Disease: From Genetics to TherapySemantic proximity Read ↗

alpha-synuclein and LRRK2: partners in crime.Semantic proximity Read ↗

The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.Semantic proximity Read ↗

DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's DiseaseSemantic proximity Read ↗

Plasma DYRK1A as a novel risk factor for Alzheimer’s diseaseSemantic proximity Read ↗

Genetic association between Alzheimer disease and the alpha-synuclein gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.